ArticleCell death discovery2026

IOA-244, a novel p110δ PI3K inhibitor, blocks breast tumour progression on either mono- or combined-therapy.

Evangelia Goulielmaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.